menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Bio News

>

Brian Brow...
source image

Bioengineer

2d

read

0

img
dot

Image Credit: Bioengineer

Brian Brown, Ph.D., Honored with Induction into AIMBE College of Fellows for Groundbreaking Work in Gene Therapy and Functional Genomics

  • Dr. Brian Brown, Director of Icahn Genomics Institute at Mount Sinai, has been inducted into the AIMBE College of Fellows for his pioneering work in gene therapy and functional genomics.
  • This recognition acknowledges Dr. Brown's significant contributions to medical and biological engineering, positioning him as a leader in the field.
  • His advancements have led to innovative technologies in oncology, immunology, and genetic disease treatment, reshaping possibilities in medicine.
  • Dr. Brown's focus on gene therapy techniques like synthetic microRNA target sites and macrophage-targeting CAR T cells shows promise in cancer therapy.
  • His developments in mRNA delivery systems and genome-wide microRNA sensor libraries are revolutionizing treatments and personalized medicine.
  • The Pro-Code technology and Perturb-map platform developed by Dr. Brown support drug discovery and single-cell level analysis for cancer therapies.
  • Dr. Brown envisions a future where technology and patient-centered care align to improve outcomes, emphasizing collaboration and innovation.
  • Being inducted into AIMBE College of Fellows highlights Mount Sinai's dedication to biomedical research excellence and patient care advancements.
  • Dr. Brown's leadership extends to mentoring the next generation of scientists, fostering diversity of thought and innovation in research settings.
  • His recognition signifies a milestone in biomedical engineering and signals future breakthroughs that can address emerging health challenges.

Read Full Article

like

Like

For uninterrupted reading, download the app